Does Topical Ophthalmic Proparacaine 0.5% Prior to Probing and Irrigation Decrease Pain?

Part of paid clinical trials in New Orleans, Louisiana.

Sponsor
Louisiana State University Health Sciences Center in New Orleans
Study ID
NCT05663684
Phase
PHASE4
Status
Recruiting

Conditions

  • Dacryocystitis
  • Dacryostenosis
  • Epiphora

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Proparacaine Hydrochloride ophthalmic solution, USP 0.5% — DRUG
    One drop instilled in one eye, randomly chosen, as topical anesthetic
  • Balanced salt solution — DRUG
    One drop instilled in one eye, randomly chosen, as control placebo

Study Details

Purpose: It is unknown whether instillation of a drop of anesthetic ophthalmic solution into the eye such as proparacaine hydrochloride 0.5% prior to probing and irrigation of the tear duct (lacrimal drainage) system improves participant comfort during the procedure. To date, there have been no formal studies evaluating the possible benefit of this pretreatment. Methods: Participants 18 years and older who present to the Louisiana State University or associated outpatient ophthalmology clinic(s) with a complaint of epiphora (excessive tearing) who necessitate bilateral lower lid probing and irrigation of the lacrimal drainage system will be enrolled in the study. One eye will be randomized to receive a drop of the anesthetic Proparacaine hydrochloride 0.5% and the other eye will receive a control drop of Balanced Salt Solution (BSS). Probing and irrigation will then be performed in the usual fashion. The participant will then be questioned via survey on a pain scale of 1-5 as to the amount of subjective pain experienced on each side during the procedure. Expected Results: Investigators expect participants will experience statistically significantly less pain in eyes that have received a drop of Proparacaine hydrochloride 0.5% prior to performance of probing and irrigation compared to the eyes which have received the control drop.

Key Dates

Start date
Jun 30, 2020
Status verified
Dec 2022
Primary completion
Dec 30, 2022
Completion
Jan 31, 2023

Study Design

Enrollment
145 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Participants with no obstruction of the lacrimal system
    Patients will have received a drop of Proparacaine Hydrocholoride 0.5% ophthalmic solution in one eye and a drop of BSS in the other eye prior to probing and irrigation.
  • Experimental: Participants with obstruction of the lacrimal system
    Participants who have a blockage in their tear drainage system on probing and irrigation. Participants will have received a drop of Proparacaine Hydrocholoride 0.5% ophthalmic solution in one eye and a drop of BSS in the other eye prior to probing and irrigation.

Primary Outcome Measure

Association between reduction of pain/discomfort and anesthetic use [ Time Frame: 1 minute ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Louisiana State University Health Sciences CenterNew OrleansLouisiana70112-

Find similar trials in New Orleans, LA